7 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... #OIs #HIVAIDS # ... IDSA #management ... #pharmacology
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
hospital For empiric ... define the type of infection ... , then review prior ... ampicillin #management ... #antibiogram #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Herpes Simplex Virus ... HerpesSimplex #HSV #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Antimicrobial Regimens for Acute Bacterial Rhinosinusitis in Adults
Initial empirical therapy: 
 • Amoxicillin-clavulanate (500 mg/125 mg
Adults Initial empirical ... PO qd) Severe infection ... #idsa #antibiotics ... Rhinosinusitis #Adults #management ... #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... Varicella Zoster Virus ... #Zoster #VZV #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... diagnostic tests, empiric ... Tuberculosis #TB #IDSA ... Prevention #Treatment #management ... #HIVAIDS #pharmacology